SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-727545
Filing Date
2016-09-30
Accepted
2016-09-30 16:05:56
Documents
5
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 6-K d257301d6k.htm 6-K 11166
2 EX-1.1 d257301dex11.htm EX-1.1 194645
3 EX-99.1 d257301dex991.htm EX-99.1 47930
4 GRAPHIC g257301img1.jpg GRAPHIC 5383
5 GRAPHIC g257301img2.jpg GRAPHIC 7359
  Complete submission text file 0001193125-16-727545.txt   272530
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 161912949
SIC: 2834 Pharmaceutical Preparations